3 ·Filed Apr 1, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
Monitor for subsequent Form 4 filings or amended disclosures that may reveal actual share holdings or transactions. The lack of quantitative data limits immediate trading implications.
Price Chart
Loading chart...
Executive Summary
Ware J. Anthony filed a Form 3 disclosing initial beneficial ownership of securities in First Tracks Biotherapeutics, Inc. (TRAX), a biopharma company formerly known as Biopharma Company, Inc. The filing is a standard insider ownership disclosure and does not include any transaction details or share quantities.
Key Facts
- Form 3 filed by Ware J. Anthony for First Tracks Biotherapeutics, Inc. (TRAX)
- Filing type indicates initial statement of beneficial ownership
- No specific share amounts, values, or transaction details disclosed in available documents
- Company previously named Biopharma Company, Inc., changed name on October 10, 2025
- Company is incorporated in Delaware and operates in the life sciences sector
Financial Impact
undisclosed amount
insider ownershipshare structure
Risk Factors
- Insufficient data to assess ownership size or potential insider activity
- No indication of whether this reflects a new board appointment, executive role, or passive investment
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001715429-26-000002 |
| Document: 0001715429-26-000002-index.html | 0001715429-26-000002 |
| Document: 0001715429-26-000002.txt | 0001715429-26-000002 |
20 reports for TRAX
80% Hit rate @ T+1 Went positive at some point 4 of 5 best @ T+5▲ +30.21%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | S-1 | $43.80 | awaiting T+1 | — | $44.05 (+0.57%) |
Oct 20, 2026 5d ago | 8-K | $42.77 $43.14 | ▲ +0.87% | ▲ +2.05% | $44.05 (+2.99%) |
Oct 15, 2026 10d ago | 8-K | $34.46 $36.28 | ▼ −5.28% | ▼ −4.86% | $44.05 (−27.83%) |
Oct 15, 2026 11d ago | Press Release | $36.04 $34.46 | ▲ +4.38% | ▲ +3.28% | $44.05 (−22.23%) |
Oct 13, 2026 13d ago | 8-K | $31.68 $34.13 | ▲ +7.73% | ▲ +8.81% | $44.05 (+39.05%) |
Aug 12, 2026 10w ago | 8-K | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 12, 2026 10w ago | Press Release | $44.03 $44.04 | ▲ +0.02% | ▲ +0.22% | $44.05 (+0.05%) |
Aug 7, 2026 11w ago | 3/A | $47.92 $46.75 | ▼ −2.44% | ▼ −2.12% | $44.05 (−8.08%) |
Jun 22, 2026 17w ago | 8-K | $17.78 $16.69 | ▼ −6.13% | ▼ −6.08% | $44.05 (+147.75%) |
May 14, 2026 23w ago | 8-K | $16.90 $17.79 | ▲ +5.27% | ▲ +5.33% | $44.05 (+160.65%) |
Showing 10 of 20
US Market Status
Market Closed — Opens in 20m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers